Evaluation of bovine spongiform encephalopathies (BSE) - risk via the use of materials of bovine origin in or during the manufacture of vaccines

  • Email
  • Help
Current version

Public statement

Reference numberEMEA/CPMP/BWP/476/01
Published28/02/2001
KeywordsBovine spongiform encephalopathies (BSE), risk assessment, materials of bovine origin, vaccines
DescriptionThis document aims to assess the risk of the use of materials of bovine origin in or during the manufacture of vaccines.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more